Hoddesdon

Pharmaron Appoints Dr. Antony Davies as Senior Vice President, UK CMC

Retrieved on: 
Monday, January 17, 2022

Pharmaron Beijing Co., Limited (Stock Code: 300759.SZ/3759.HK) (Pharmaron) today announced the appointment of Dr. Antony (Tony) Davies as Senior Vice President, UK CMC, effective January 10, 2022.

Key Points: 
  • Pharmaron Beijing Co., Limited (Stock Code: 300759.SZ/3759.HK) (Pharmaron) today announced the appointment of Dr. Antony (Tony) Davies as Senior Vice President, UK CMC, effective January 10, 2022.
  • The UK Chemistry, Manufacturing and Control (CMC) business includes operations in Hoddesdon and Cramlington, UK.
  • Tony has been Senior Vice President, Process R&D, since 2019, having been promoted from Vice President, Process Chemistry, a post he held since Pharmaron acquired the MSD Hoddesdon site in 2016.
  • The UK CMC business currently includes operations in Hoddesdon and Cramlington, UK.

Pharmaron Acquires Commercial API Manufacturing Facility in the United Kingdom from Recipharm

Retrieved on: 
Monday, January 10, 2022

The Cramlington Site in Newcastle, United Kingdom, has an established history of cGMP manufacturing services for an array of Active Pharmaceutical Ingredients (API), ranging from pilot scale to commercial metric ton scale.

Key Points: 
  • The Cramlington Site in Newcastle, United Kingdom, has an established history of cGMP manufacturing services for an array of Active Pharmaceutical Ingredients (API), ranging from pilot scale to commercial metric ton scale.
  • This acquisition expands Pharmaron's world-class chemistry and manufacturing services, which is an important component of its fully integrated platform.
  • The synergistic integration of the Cramlington Site with Pharmarons existing service capabilities of discovery, process development and early-stage cGMP API manufacturing at Hoddesdon will enable a complete end-to-end chemistry and manufacturing service offering in the United Kingdom.
  • Dr. Boliang Lou, Chairman and Chief Executive Officer of Pharmaron, commented, We are delighted to have the Cramlington Site join the Pharmaron Group.